{"transactions":[{"id":1979707,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":116153,"kind":"person","name":"Roth Iris","position":1,"cik":"0001964808","reported_name":"Roth Iris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-02T21:30:11.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":297500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest over four years: 25% of the options will vest on February 6, 2024, with the remaining 75% vesting in equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":297500,"derivative":{"exercise_price":18.87,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":297500},"source":{"system":"sec-edgar","filing":"0001725160-23-000050","document":"wf-form4_167779259154330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000050/wf-form4_167779259154330.xml","form_type":"4"}},{"id":1979706,"issuer":{"id":5772,"kind":"organization","name":"Zentalis Pharmaceuticals, Inc."},"owners":[{"id":116153,"kind":"person","name":"Roth Iris","position":1,"cik":"0001964808","reported_name":"Roth Iris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-03-02T21:30:11.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments on the first, second, third and fourth anniversaries of the vesting commencement date of Feb. 6, 2023, subject to the Reporting Person's continuing service with the Issuer."}],"balance_after":52500,"source":{"system":"sec-edgar","filing":"0001725160-23-000050","document":"wf-form4_167779259154330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1725160/000172516023000050/wf-form4_167779259154330.xml","form_type":"4"}}]}